Ticker Details
GoodRx Holdings, Inc.
IPO Date:	September 23, 2020
Sector:	Healthcare
Industry:	Health Information Services
Market Cap:	$897.49M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.46 | 3.16%
Avg Daily Range (30 D):	$0.07 | 2.58%
Avg Daily Range (90 D):	$0.08 | 3.25%

Institutional Daily Volume
Avg Daily Volume:	1.94M
Avg Daily Volume (30 D):	1.68M
Avg Daily Volume (90 D):	2.37M

Trade Size
Avg Trade Size (Sh.):	125
Avg Trade Size (Sh.) (30 D):	159
Avg Trade Size (Sh.) (90 D):	190

Institutional Trades
Total Institutional Trades:	2,664
Avg Institutional Trade:	$1.83M
Avg Institutional Trade (30 D):	$.54M
Avg Institutional Trade (90 D):	$1M
Avg Institutional Trade Volume:	.09M
Avg Institutional Trades (Per Day):	3

Market Closing Trades
Avg Closing Trade:	$2.23M
Avg Closing Trade (30 D):	$.58M
Avg Closing Trade (90 D):	$1.03M
Avg Closing Volume:	127.57K

News

May 10, 2026 @ 12:24 PM GoodRx vs. Hims & Hers Health: Stagnation vs. Grow... Source: Cory Renauer

Apr 15, 2026 @ 5:25 PM GoodRx Rallies As Wegovy HD Rollout Targets Self-P... Source: Vandana Singh

Feb 6, 2026 @ 1:15 AM Amazon Is Now Offering Novo Nordisk's Wegovy Pill ... Source: Reuben Gregg Brewer

Jan 5, 2026 @ 5:23 PM Novo Nordisk's Wegovy Weight Loss Pill Hits US Pha... Source: Vandana Singh

Nov 17, 2025 @ 6:01 PM Novo Nordisk Leans Into Affordability Amid Rising ... Source: Vandana Singh

Financials
	TTM	Q1 2026	Q4 2025
Basic EPS	$.06	$	$.02
Diluted EPS	$.06	$	$.02
Revenue	$787.89M	$194.01M	$194.79M
Gross Profit
Net Income / Loss	$20.56M	$1.17M	$5.43M
Operating Income / Loss	$78.12M	$14.01M	$22.68M
Cost of Revenue
Net Cash Flow	$-65.27M	$-26.11M	$-11.71M
PE Ratio